
Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials
Author(s) -
Μenelaos Zafrakas,
Panayiota Papasozomenou,
Christos Emmanouilides
Publication year - 2016
Publication title -
world journal of clinical oncology
Language(s) - English
Resource type - Journals
ISSN - 2218-4333
DOI - 10.5306/wjco.v7.i4.331
Subject(s) - sorafenib , medicine , capecitabine , breast cancer , oncology , bevacizumab , anastrozole , ixabepilone , vinorelbine , clinical trial , gemcitabine , cancer , metastatic breast cancer , tamoxifen , chemotherapy , hepatocellular carcinoma , colorectal cancer , cisplatin
To evaluate the current role of sorafenib, an oral multikinase inhibitor in the treatment of breast cancer.